If you aren’t losing weight with GLP-1s, this may be one reason why
Key Points:
- A new study suggests that two genes related to gut hormones affecting appetite and digestion may influence individual responses to GLP-1 weight loss drugs.
- GLP-1 drugs have transformed obesity and diabetes treatment but show varied effectiveness among patients.
- Approximately 10 to 15 percent of users are "non-responders," failing to lose at least 5 percent of their body weight during clinical trials.
- Side effects such as nausea and vomiting lead some patients to discontinue the medication despite its potential benefits.